![](/img/cover-not-exists.png)
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Robertson, John F R, Bondarenko, Igor M, Trishkina, Ekaterina, Dvorkin, Mikhail, Panasci, Lawrence, Manikhas, Alexey, Shparyk, Yaroslav, Cardona-Huerta, Servando, Cheung, Kwok-Leung, Philco-Salas, ManLanguage:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)32389-3
Date:
November, 2016
File:
PDF, 462 KB
english, 2016